story of the week
Anti-Emesis: IV Fosaprepitant Noninferior to Oral Aprepitant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology